Resource Center › Compliance
Ohio TDDD (Terminal Distributors of Dangerous Drugs)
Ohio requires TDDD licensure verification before drug samples are delivered to Ohio HCPs. Here is what the rule requires and how MedPro Systems verifies address eligibility.
Ohio Board of Pharmacy
Ohio Admin. Code 4729-9-12
The practice address must hold a TDDD license
Dangerous drug samples delivered to Ohio HCPs
Overview
The Dangerous Drug Act, which encompasses Ohio’s Terminal Distributors of Dangerous Drugs (TDDD) licensure, was signed into law in 1961. As a result, specific practices in Ohio had to obtain a TDDD license to handle or possess dangerous drugs. The verification rule (Admin. Code 4729-9-12) has been included in the Dangerous Drug Act for decades; however, the rule was amended in June 2017 with modifications to exemptions related to practice type. In July 2017, the Ohio Board of Pharmacy further clarified that TDDD licensure verification is required for delivery of drug samples to Ohio Healthcare Professionals (HCPs).
For HCPs to receive a dangerous drug sample in Ohio, their practice address must be TDDD licensed.
How MedPro Systems Can Help
To help Life Sciences companies achieve this level of verification, the MedProID® suite of products uses TDDD licenses in Ohio collected in our Healthcare Organization (HCO) database to obtain overall address eligibility for Ohio HCPs.
Ohio TDDD license validation is fully supported across the entire MedProID suite of solutions.
FAQ
Frequently Asked Questions
Work With Us
Demo the Difference
Try MedProID free for two weeks, including a no-cost validation of your own data.
Related resources
-
Provider Verification Beyond Compounding Pharmacy Onboarding
How current provider and facility information supports documented decisions from account setup through order fulfillment.
-
Where Prescriber Verification Fits in the Specialty Pharmacy Workflow
A practical look at verification checkpoints from prescription intake through dispensing and the value of current provider data at each stage.
-
7 Workflow Gaps That Slow Down Life Sciences Compliance Teams
As compliance responsibilities grow, small gaps between data, systems and teams can create extra manual work. Here are 7 places to look first and practical steps your team can take to strengthen the workflow.
-
Two International Disclosure Dates to Plan For
Colombia’s biannual value-transfer filing is due September 30, and Japan’s annual disclosure window follows each company’s fiscal year end.
